|
METTL6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.582340E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.684300E-02 |
| Normal-vs-Stage2 |
2.442800E-01 |
| Normal-vs-Stage3 |
1.767550E-01 |
| Normal-vs-Stage4 |
7.984600E-01 |
| Stage1-vs-Stage2 |
8.348800E-01 |
| Stage1-vs-Stage3 |
9.045200E-01 |
| Stage1-vs-Stage4 |
4.979800E-01 |
| Stage2-vs-Stage3 |
9.307800E-01 |
| Stage2-vs-Stage4 |
4.763600E-01 |
| Stage3-vs-Stage4 |
4.553600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.123750E-02 |
| Normal-vs-AfricanAmerican |
1.453230E-01 |
| Normal-vs-Asian |
2.914200E-01 |
| Caucasian-vs-AfricanAmerican |
4.288000E-01 |
| Caucasian-vs-Asian |
9.247800E-01 |
| AfricanAmerican-vs-Asian |
8.545400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.008200E-01 |
| Normal-vs-Female |
1.360470E-04 |
| Male-vs-Female |
5.213000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.138400E-01 |
| Normal-vs-Extreme_Weight |
1.801400E-01 |
| Normal-vs-Obese |
3.209800E-02 |
| Normal-vs-Extreme_Obese |
3.193200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.142200E-01 |
| Normal_Weight-vs-Obese |
2.667400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.985600E-01 |
| Extreme_Weight-vs-Obese |
3.080200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.756200E-01 |
| Obese-vs-Extreme_Obese |
7.209800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.716700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.978200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.067800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.993000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.535200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.743500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.736100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.467800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.868400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.366400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.304110E-02 |
| Normal-VS-Type2 PRCC |
7.618400E-01 |
| Normal-VS-KIRP CIMP |
9.622300E-04 |
| Normal-VS-Unclassified PRCC |
5.424300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.009100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.503700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.379400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.249700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.940100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.659400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.902200E-01 |
| Normal-vs-N1 |
5.965800E-02 |
| Normal-vs-N2 |
5.665000E-01 |
| N0-vs-N1 |
5.599800E-02 |
| N0-vs-N2 |
5.431000E-01 |
| N1-vs-N2 |
1.911350E-01 |
|
|
